Trifucosyl-p-lacto-N-hexose—decoding the sugar code of life CAS 120864-60-0

In the microscopic universe of life sciences, sugar chains, as the third type of life information macromolecules after nucleic acids and proteins, carry vital biological language. Among them, complex oligosaccharides with precise structures, such as trifucosyl-p-lacto-N-hexose, are increasingly becoming key codes for deciphering cell communication, immune recognition and disease mechanisms, and are empowering the R&D and innovation of next-generation biomedicines with unprecedented depth. As a type of high-purity complex oligosaccharide with clear structure and significant biological activity, trifucosyl-p-lacto-N-hexose has gone beyond the scope of basic research reagents and has become a bridge molecule connecting cutting-edge discoveries in glycoscience and translational medical applications, showing great potential in cutting-edge fields such as vaccine design, targeted therapy, precision diagnosis, and cell engineering.

1. Molecular core information: definition of precise structure

Chemical name: Trifucosyl-p-lacto-N-hexose

Common name/description: Fucosylated milk-N-hexose derivative, core structural unit of Lewis X/a and other related epitopes

Chemical formula: C₅₈H₉₈N₂O₄₃

Molecular weight: 1511.39 g/mol

CAS number: 120864-60-0

2. Structural uniqueness: the molecular cornerstone of biological functions

The core value of this molecule stems from its exquisite and defined three-dimensional chemical structure:

Highly specific fucosylation pattern: Its structure is based on the Lacto-N-hexaose skeleton, and three fucose (Fucose) residues are precisely modified through α1,2-, α1,3- or α1,4-linkage on specific Gal (galactose) or GlcNAc (N-acetylglucosamine) residues. Far from being random, this precise pattern of modifications is a "molecular signature" of key biorecognition events in nature.

Carrier of core biorecognition epitopes: This structure is the core component of various Lewis antigens (such as Lewis X, Lewis A, Lewis Y) and their derivatives. These antigens play a decisive role in embryonic development, cell differentiation, inflammatory response, and tumorigenesis and metastasis. They are "identity tags" for the dialogue between cells, cells, matrix, and host and pathogens.

Stable conformation and binding affinity: The unique glycosidic linkage gives the molecule a stable spatial conformation, allowing it to bind to a series of lectin family receptors with high affinity and specificity, including selectins, galectins, Siglecs, etc. This interaction directly regulates key physiological and pathological processes such as lymphocyte homing, inflammatory cell recruitment, immune activation and suppression.

3. Diversified application scenarios: from basic scientific research to clinical transformation

1. The “Rosetta Stone” of cutting-edge glycobiology research

Enzymatic mechanism analysis: As a high-quality substrate with a clear structure, it is used for in-depth study of the catalytic characteristics, kinetic parameters and inhibitor screening of key glycosylases such as fucosyltransferases (FUTs), laying the foundation for the development of regulatory drugs for related enzymes.

Glyco-protein interaction mapping: It is the perfect probe to characterize and identify novel glyco-binding proteins (GBPs), to reveal unknown glyco-recognition domains (CRDs), and to expand our understanding of complex cellular signaling networks.

Reference standard for cell surface glycomics research: Used as an internal standard or external standard in mass spectrometry analysis to help accurately and quantitatively analyze the dynamic changes in surface sugar chain expression profiles of cells under disease conditions.

2. Strategic raw materials for innovative drug development

Next generation glycoconjugate vaccine design:

Anti-tumor vaccine: Coupling this molecule with a carrier protein can simulate specific sugar antigens (such as Lewis Y) overexpressed on the surface of tumor cells, stimulating the body to produce potent and specific antibody responses. It is a star candidate antigen for the development of therapeutic cancer vaccines.

Anti-infectious vaccines: Many pathogens (e.g., Helicobacter pylori, certain strains of E. coli) utilize similar fucosylation structures to attach to host cells. Vaccines based on this structure can induce the production of blocking antibodies to prevent or treat infection.

Navigation head for targeted drugs and delivery systems: Utilizing its specific binding ability to highly expressed receptors at disease sites, the oligosaccharide or its mimetic can be connected to drugs, nucleic acids or imaging agents to achieve active targeted treatment and diagnosis of diseases, improve efficacy and reduce systemic toxicity.

Lead compound for anti-inflammatory and anti-adhesion therapy: By competitively inhibiting the binding of selectins and their endogenous ligands at high concentrations, it can effectively block the excessive recruitment of leukocytes at inflammatory sites and provide a core structural framework for the development of new anti-adhesion drugs for the treatment of autoimmune diseases, ischemia-reperfusion injury and cancer metastasis.

3. A powerful tool for precise diagnosis and biomarker discovery

Development of high-sensitivity diagnostic reagents: As a coated antigen, it is used to develop ELISA kits for detecting specific anti-sugar antibodies (such as autoantibodies and infection-related antibodies) in serum, serving the early screening of autoimmune diseases, cancer and diagnosis of infectious diseases.

New biomarker verification tool: As a standard, it assists in detecting specific sugar chain structures that are free or carried by exosomes in blood, urine or other body fluids, and evaluates their potential as markers for non-invasive diagnosis and prognosis of diseases (especially cancer).

4. Quality guard in the production of advanced therapeutic products

Functional modulators for cell therapy products: Specific oligosaccharides can simulate the stem cell microenvironment and be added to the culture medium to guide the directional differentiation of stem cells, or enhance the homing and killing functions of specific immune cells (such as NK cells, CAR-T cells).

Glycosylation quality control reference material for biological products: In the production of biological drugs such as therapeutic antibodies and recombinant proteins, the glycosylation pattern directly affects the stability, half-life and effector function of the product. As a key reference standard, it is used to monitor and ensure the consistency and compliance of glycosylation modifications during the production process.

Conclusion

Trifucosyl-p-lacto-N-hexose, this seemingly complex molecule is actually a golden key to unlock the treasure at the intersection of glycoscience and modern medicine. From elucidating the most basic intercellular dialogue mechanisms to producing the most breakthrough targeted therapies and precise diagnostic tools, its value chain is constantly extending.

The above information is provided by the editor of KASONS and is for scientific research only.